Results for "consumer data right"
671-680 of 817 results for 'consumer data right'
New restrictions on foreign persons acquiring Australian land and agribusinesses
The Federal Treasurer has today announced material changes to Australias foreign investment regime which will significantly impact transactions undertaken by foreign persons of Australian land particularly agricultural land and agribusinesses Partner Wendy Rae and Senior Associate Nick Kefalianos ...
New reporting requirements for critical infrastructure
New reporting requirements for critical infrastructure require the lodgement of information on the Register of Critical Infrastructure Assets before 11 January 2019 ...
Revisions to FIRB Guidance Note 23: clarity for foreign government investors
Recent reforms to the Foreign Acquisitions and Takeovers Act 1975 Cth introduced new provisions that deem foreign government investors of the same country to be associates of each other These provisions have created practical difficulties for foreign government investors who risk unintentionally ...
High Court refuses liquidator special leave to appeal in unreasonable director-related transaction case
Last year, we published an Insight on a Federal Court decision where the plaintiff liquidator was successful in having a mortgage declared an unreasonable director-related transaction under s 588FDA o ...
ASIC's New Document Production Guidelines
ASIC has released its new Document Production Guidelines, which govern how it expects electronic and hard copy records to be produced in response to compulsory notices. ...
FIRB changes to note from 1 July 2023
In this Insight, we outline and comment on the New Register and corresponding reporting obligations. ...
Revised Banking Code of Practice, innovation at the ASX and other corporate law developments
Revised Banking Code of Practice; innovation at the ASX; and other corporate law developments. ...
Interlocutory injunction refused based on 'doubtful' patent term extension
In the fight against patent infringement, challenging the validity of patent term extensions (PTEs) is increasingly becoming the weapon of choice for generic pharmaceutical companies. Since around the mid-2000s, patentees in pharmaceutical patent cases have typically been successful in bids for interlocutory injunctions, aiming to prevent the launch of generic products in Australia. The recent Biogen decision by the Federal Court is the latest in a trend of refusing interlocutory injunctions, and a clear indication the tide is turning. ...
Regulatory scrutiny of private capital increases
Private capital is becoming a growing focus of regulators, both in Australia and internationally, given the ever-increasing flow of capital to the sector in recent years. ...
Report: National Electricity & Gas Rules Update: February 2019
In this update we summarise the progress of new and existing rule change requests across the month of February and take a closer look at the ACCCs new consultation paper on the approach for implementing the Consumer Data Right in the energy sector ...